Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia [Phase 2]
Phase 2 placebo-controlled study of MR901 (talaporfin sodium with a drug-activating device) in benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms [Phase 3]
Phase 3 trial update on MCS-2 for lower urinary tract symptoms and benign prostatic hyperplasia reports efficacy and safety data.
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT [NA]
This clinical trial update compares ejaculation-preserving photoselective vaporization, plasma kinetic vaporization, and transurethral resec…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands
Clinical trial update reporting outcomes and complications of Holmium laser enucleation of the prostate (HoLEP) performed by expert surgeons…
-
CLINICAL_TRIALS research · 2018-07-10Clinical Trial Update: Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
This clinical trial update reports development and initial clinical assessment of a prostate cancer risk model based on an updated circulati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia [Phase 1]
A Phase 1 study evaluated several formulations of a fixed-dose combination containing dutasteride 0.5 mg and tamsulosin 0.2 mg to identify a…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects [Phase 1]
Phase 1 bioavailability study comparing a fixed-dose combination of dutasteride and tamsulosin HCl to separate dutasteride and tamsulosin ta…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. [Phase 1]
Phase 1 bioavailability study of two combination products containing dutasteride 0.5 mg and tamsulosin 0.2 mg, evaluated in Asian male parti…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects [Phase 1]
A Phase 1 study conducted by GlaxoSmithKline compared the bioavailability of a novel dutasteride formulation to the soft gel capsule in heal…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects [Phase 1]
Phase 1 bioequivalence study of dutasteride capsules in healthy Japanese male subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States [Phase 1]
Phase 1 study evaluating the relative bioavailability of two fixed-dose combination formulations of dutasteride and tamsulosin hydrochloride…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples [Phase 1]
Phase 1 open-label study evaluating pharmacokinetics, safety, and drug–drug interactions of dutasteride and tamsulosin when administered alo…
-
FDA approval · 2018-05-24FDA Approved: DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the generic fixed-dose combination dutasteride and tamsulosin hydrochloride from Zydus Pharmaceuticals USA Inc. (Original Appli…
-
FDA approval · 2018-05-14FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma US Corp.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia [Phase 4]
Phase 4 trial comparing GreenLight XPS laser to BiVAP saline vaporization for symptomatic Benign Prostatic Hyperplasia has been completed an…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. [NA]
A completed clinical trial evaluating the efficacy and safety of transarterial supraselective embolization of the prostate to treat urinary …
-
CLINICAL_TRIALS research · 2018-04-20Clinical Trial Update: Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate [NA]
This clinical trial update compares Bipolar Transurethral Enucleation (BipolEP) with Bipolar Transurethral Resection of the Prostate for ben…
-
FDA approval · 2018-04-17FDA Approved: DOXAZOSIN — Original Application (Upsher-Smith laboratories, LLC)
The FDA granted approval of Upsher-Smith's original application for doxazosin mesylate, making doxazosin available as a generic product. Dox…
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia [Phase 4]
An open-label Phase 4 trial evaluated the efficacy of fesoterodine (Toviaz) after surgery for benign prostatic hyperplasia; results were pos…
-
CLINICAL_TRIALS withdrawal · 2018-04-04Clinical Trial Update: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
A clinical trial evaluating the PlasmaButton Vaporization Electrode for symptomatic benign prostatic hyperplasia in patients on anticoagulan…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH [NA]
Completed trial evaluating HoLEP at 50W versus 100W for benign prostatic hyperplasia.
-
CLINICAL_TRIALS research · 2018-03-27Clinical Trial Update: Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship
This clinical trial update reports on the learning curve for performing digital rectal examinations to detect prostate cancer among medical …
-
CLINICAL_TRIALS withdrawal · 2018-03-20Clinical Trial Update: Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men [NA]
A clinical trial sponsored by St. Louis University evaluating minimally invasive options for urinary problems related to prostate enlargemen…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System
An observational study assessing the cardiovascular effects of Thrupas Capsule in individuals with Benign Prostatic Hyperplasia; the study h…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction [Phase 2]
A Phase 2 clinical trial compares irreversible electroporation against standard medication for benign prostatic obstruction. The current sta…